| 注册
首页|期刊导航|医药导报|精准医疗下药物临床试验中伴随诊断试剂研究的管理与实践

精准医疗下药物临床试验中伴随诊断试剂研究的管理与实践

冯钰 储天晴 颜波 陈仲林

医药导报2026,Vol.45Issue(6):1044-1050,7.
医药导报2026,Vol.45Issue(6):1044-1050,7.DOI:10.3870/j.issn.1004-0781.2026.06.015

精准医疗下药物临床试验中伴随诊断试剂研究的管理与实践

Management and Practice of Companion Diagnostic Reagents Research in Drug Clinical Trials Within the Framework of Precision Medicine

冯钰 1储天晴 1颜波 1陈仲林1

作者信息

  • 1. 上海市胸科医院,上海交通大学医学院附属胸科医院临床研究中心,上海 200030
  • 折叠

摘要

Abstract

Objective From the perspective of clinical trial institutions,to analyzes the multiple compliance challenges associated with the research and application of companion diagnostic reagents in drug clinical trials within the framework of preci-sion medicine,and proposes targeted management strategies.Methods Through literature review and interpretation of relevant regulations and policies,this study compared the differences in the supervision model of companion diagnostic reagent clinical tri-als between China and other countries.Furthermore,combined with practical experiences,the pivotal compliance challenges ex-isting in companion diagnostic reagent clinical trials in China were summarized.Results Within the distinctive"dual-track"supervision model of clinical trials in China,the traditional management approach"separate management of drugs and devices"has had obvious conflicts with the"cross domain"attribute of companion diagnostic reagents.Based on the current management system,compliance risks of companion diagnostic reagents clinical trials may arise in three key aspects:approval path,use of tri-al participants' biological samples and personal information disclosure,and human genetic resources management.Conclusions Clinical trial institutions should establish an"identification"mechanism for the full life cycle of companion diagnostic reagents clinical trials,construct a"separate project approval"mode,and carry out"intensive"management.By implementing the core strategy of"one set of materials,separate submission and integrated management",clinical trial institutions can strictly control risk points,so as to achieve the dual objectives of normative supervision and efficient operation.

关键词

精准医疗/药物临床试验/伴随诊断试剂/集约化管理

Key words

Precision medicine/Drug clinical trial/Companion diagnostic reagent/Intensive management

分类

医药卫生

引用本文复制引用

冯钰,储天晴,颜波,陈仲林..精准医疗下药物临床试验中伴随诊断试剂研究的管理与实践[J].医药导报,2026,45(6):1044-1050,7.

基金项目

2023年上海申康医院发展中心《促进市级医院临床技能与临床创新三年行动计划》研究型医师创新转化能力培训项目(SHDC2023CRS046). (SHDC2023CRS046)

医药导报

1004-0781

访问量0
|
下载量0
段落导航相关论文